IONAMIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ionamin, and what generic alternatives are available?
Ionamin is a drug marketed by Ucb Inc and is included in one NDA.
The generic ingredient in IONAMIN is phentermine resin complex. There are seventeen drug master file entries for this compound. Additional details are available on the phentermine resin complex profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for IONAMIN?
- What are the global sales for IONAMIN?
- What is Average Wholesale Price for IONAMIN?
Summary for IONAMIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 31 |
| Clinical Trials: | 2 |
| Patent Applications: | 3,809 |
| DailyMed Link: | IONAMIN at DailyMed |
Recent Clinical Trials for IONAMIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| New York State Psychiatric Institute | Phase 4 |
| AstraZeneca | Phase 4 |
| Nutrition 21, Inc. | Phase 2 |
US Patents and Regulatory Information for IONAMIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ucb Inc | IONAMIN | phentermine resin complex | CAPSULE, EXTENDED RELEASE;ORAL | 011613-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Ucb Inc | IONAMIN | phentermine resin complex | CAPSULE, EXTENDED RELEASE;ORAL | 011613-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
